Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Targeted serum metabolomics (CHRIS baseline)
x0pt023a
Pro assay flags
Proline flags
Categorical
ECG 10s (CHRIS baseline)
x0ec150z34
Probable inferoposterior infarction
Token «probable inferoposterior infarction» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150z35
Probable posterolateral infarction
Token «probable posterolateral infarction» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec150z36
Probable stage III septal infarction
Token «probable stage III septal infarction» is present in automated diagnosis
Boolean
Urine measurements (CHRIS baseline)
x0lp55
Proteins, urine
Proteins, urine
Integer
Blood measurements (CHRIS baseline)
x0lp02a
Prothrombin time (PT)
Prothrombin time (PT)
Float
Food frequency questionnaire (CHRIS baseline)
x0ff126
Prunes, plums
Prunes, plums
Categorical
Drugs summary (CHRIS baseline)
x0dd39
Psychoanaleptics
Psychoanaleptics
Categorical
Major psychiatric diagnoses (CHRIS baseline)
x0mp15c
Psychogenic pain (1st degree relative affected)
Psychogenic pain: Relatives affected?
Categorical
Major psychiatric diagnoses (CHRIS baseline)
x0mp15
Psychogenic pain (affected by)
Psychogenic pain: Affected?
Categorical
Major psychiatric diagnoses (CHRIS baseline)
x0mp15b
Psychogenic pain (age at onset)
Psychogenic pain: Age at onset
Integer
Major psychiatric diagnoses (CHRIS baseline)
x0mp15a
Psychogenic pain (diagnosed)
Psychogenic pain: Diagnosed?
Categorical
Drugs summary (CHRIS baseline)
x0dd38
Psycholeptics
Psycholeptics
Categorical
Heart failure (CHRIS baseline)
x0hf02
Pulmonary edema
Do you have 'water in the lung' (pulmonary edema)?
Categorical
Heart failure (CHRIS baseline)
x0hf02b
Pulmonary edema (since)
Since when? (age)
Integer
Circulation (CHRIS baseline)
x0ci05
Pulmonary embolus/blood clots in the lungs (diagnosed)
Has a doctor ever told you that you had pulmonary embolus or blood clots in your lungs?
Categorical
Migraine (CHRIS baseline)
x0mg07
Pulsating/throbbing quality (migraine)
Do you have a headache … with pulsating or throbbing quality?
Categorical
Blood pressure (CHRIS baseline)
x0bp03a
Pulse, 1st measurement, OMRON
Pulse (1st measurement)
Integer
Blood pressure (CHRIS baseline)
x0bp03b
Pulse, 2nd measurement, OMRON
Pulse (2nd measurement)
Integer
Blood pressure (CHRIS baseline)
x0bp03c
Pulse, 3rd measurement, OMRON
Pulse (3rd measurement)
Integer
Blood pressure (CHRIS baseline)
x0bp13
Pulse, CNAP
Pulse (mean over ECG 20 min)
Float
Blood pressure (CHRIS baseline)
x0bp03
Pulse, OMRON
Pulse (mean of 3 measurements)
Integer
Food frequency questionnaire (CHRIS baseline)
x0ff098
Pumpkin
Pumpkin
Categorical
Food frequency questionnaire (CHRIS baseline)
x0ff049
Pumpkin seed oil
Pumpkin seed oil
Categorical
Autonomic system (CHRIS baseline)
x0au31
Pupillomotor (development)
31. Is the most troublesome symptom with your eyes (i.e. sensitivity to bright light or trouble focusing) getting:
Categorical
Autonomic system (CHRIS baseline)
x0au27
Pupillomotor (past year)
27. In the past year, without sunglasses or tinted glasses, has bright light bothered your eyes?
Categorical
Autonomic system (CHRIS baseline)
x0au30
Pupillomotor (severity)
30. How severe is this focusing problem?
Categorical
Autonomic system (CHRIS baseline)
x0au37
Pupillomotor domain
Pupillomotor domain
Integer
Autonomic system (CHRIS baseline)
x0au28
Pupillomotor: bright light
28. How severe is this sensitivity to bright light?
Categorical
Autonomic system (CHRIS baseline)
x0au29
Pupillomotor: focusing
29. In the past year, have you had trouble focusing your eyes?
Categorical
Targeted serum metabolomics (CHRIS baseline)
x0pt024
Putrescine
Putrescine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt024a
Putrescine assay flags
Putrescine flags
Categorical
Kidney diseases (CHRIS baseline)
x0ki02b
Pyelonephritis (age at diagnosis)
In which year was it diagnosed for the first time? (age at diagnosis)
Integer
Kidney diseases (CHRIS baseline)
x0ki02d
Pyelonephritis (description/free text)
Please specify the name of the disease
Character
Kidney diseases (CHRIS baseline)
x0ki02
Pyelonephritis (diagnosed)
Was it a pyelonephritis?
Categorical
Kidney diseases (CHRIS baseline)
x0ki02c
Pyelonephritis (treatment/list)
How were you treated?
Categorical
ECG 10s (CHRIS baseline)
x0ec110a
Q-Amplitude, I
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec110b
Q-Amplitude, II
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec110c
Q-Amplitude, III
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec110g
Q-Amplitude, V1
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec110h
Q-Amplitude, V2
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec110i
Q-Amplitude, V3
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec110j
Q-Amplitude, V4
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec110k
Q-Amplitude, V5
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec110l
Q-Amplitude, V6
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec110f
Q-Amplitude, aVF
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec110e
Q-Amplitude, aVL
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec110d
Q-Amplitude, aVR
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec113
QRS Duration
Duration of QRS complex (from the beginning of the Q wave to the end of the S wave), expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec113a
QRS Duration, I
Duration of QRS complex, expressed in milliseconds, measured in lead I
Integer
ECG 10s (CHRIS baseline)
x0ec113b
QRS Duration, II
Duration of QRS complex, expressed in milliseconds, measured in lead II
Integer
ECG 10s (CHRIS baseline)
x0ec113c
QRS Duration, III
Duration of QRS complex, expressed in milliseconds, measured in lead III
Integer
ECG 10s (CHRIS baseline)
x0ec113g
QRS Duration, V1
Duration of QRS complex, expressed in milliseconds, measured in lead V1
Integer
ECG 10s (CHRIS baseline)
x0ec113h
QRS Duration, V2
Duration of QRS complex, expressed in milliseconds, measured in lead V2
Integer
ECG 10s (CHRIS baseline)
x0ec113i
QRS Duration, V3
Duration of QRS complex, expressed in milliseconds, measured in lead V3
Integer
ECG 10s (CHRIS baseline)
x0ec113j
QRS Duration, V4
Duration of QRS complex, expressed in milliseconds, measured in lead V4
Integer
ECG 10s (CHRIS baseline)
x0ec113k
QRS Duration, V5
Duration of QRS complex, expressed in milliseconds, measured in lead V5
Integer
ECG 10s (CHRIS baseline)
x0ec113l
QRS Duration, V6
Duration of QRS complex, expressed in milliseconds, measured in lead V6
Integer
ECG 10s (CHRIS baseline)
x0ec113f
QRS Duration, aVF
Duration of QRS complex, expressed in milliseconds, measured in lead aVF
Integer
ECG 10s (CHRIS baseline)
x0ec113e
QRS Duration, aVL
Duration of QRS complex, expressed in milliseconds, measured in lead aVL
Integer
ECG 10s (CHRIS baseline)
x0ec113d
QRS Duration, aVR
Duration of QRS complex, expressed in milliseconds, measured in lead aVR
Integer
ECG 10s (CHRIS baseline)
x0ec112
QRS-Dispersion
QRS dispersion is defined as the difference between the longest and the shortest QRS complex measured in the 12 ECG leads, expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec115
QT Time
Duration of QT interval (from the beginning of the Q wave to the end of the T wave), expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec115a
QT Time, I
Duration of QT interval, expressed in milliseconds, measured in lead I
Integer
ECG 10s (CHRIS baseline)
x0ec115b
QT Time, II
Duration of QT interval, expressed in milliseconds, measured in lead II
Integer
ECG 10s (CHRIS baseline)
x0ec115c
QT Time, III
Duration of QT interval, expressed in milliseconds, measured in lead III
Integer
ECG 10s (CHRIS baseline)
x0ec115g
QT Time, V1
Duration of QT interval, expressed in milliseconds, measured in lead V1
Integer
ECG 10s (CHRIS baseline)
x0ec115h
QT Time, V2
Duration of QT interval, expressed in milliseconds, measured in lead V2
Integer
ECG 10s (CHRIS baseline)
x0ec115i
QT Time, V3
Duration of QT interval, expressed in milliseconds, measured in lead V3
Integer
ECG 10s (CHRIS baseline)
x0ec115j
QT Time, V4
Duration of QT interval, expressed in milliseconds, measured in lead V4
Integer
ECG 10s (CHRIS baseline)
x0ec115k
QT Time, V5
Duration of QT interval, expressed in milliseconds, measured in lead V5
Integer
ECG 10s (CHRIS baseline)
x0ec115l
QT Time, V6
Duration of QT interval, expressed in milliseconds, measured in lead V6
Integer
ECG 10s (CHRIS baseline)
x0ec115f
QT Time, aVF
Duration of QT interval, expressed in milliseconds, measured in lead aVF
Integer
ECG 10s (CHRIS baseline)
x0ec115e
QT Time, aVL
Duration of QT interval, expressed in milliseconds, measured in lead aVL
Integer
ECG 10s (CHRIS baseline)
x0ec115d
QT Time, aVR
Duration of QT interval, expressed in milliseconds, measured in lead aVR
Integer
ECG 10s (CHRIS baseline)
x0ec150q1
QT prolongation
Token «QT prolongation» is present in automated diagnosis
Boolean
ECG 10s (CHRIS baseline)
x0ec114
QT-Dispersion
QT interval dispersion is defined as the difference between the longest and the shortest QT interval duration measured in the 12 ECG leads, expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec151b
QTc (Baz) Dispersion
QTc interval dispersion is defined as the difference between the longest and the shortest QT interval duration (with Bazett formula) measured in the 12 ECG leads, expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec153
QTc (Baz) Time
Duration of QT interval adjusted for a standard heart-rate of 60bpm with Bazett formula, expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec153a
QTc (Baz) Time, I
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead I
Integer
ECG 10s (CHRIS baseline)
x0ec153b
QTc (Baz) Time, II
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead II
Integer
ECG 10s (CHRIS baseline)
x0ec153c
QTc (Baz) Time, III
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead III
Integer
ECG 10s (CHRIS baseline)
x0ec153g
QTc (Baz) Time, V1
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead V1
Integer
ECG 10s (CHRIS baseline)
x0ec153h
QTc (Baz) Time, V2
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead V2
Integer
ECG 10s (CHRIS baseline)
x0ec153i
QTc (Baz) Time, V3
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead V3
Integer
ECG 10s (CHRIS baseline)
x0ec153j
QTc (Baz) Time, V4
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead V4
Integer
ECG 10s (CHRIS baseline)
x0ec153k
QTc (Baz) Time, V5
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead V5
Integer
ECG 10s (CHRIS baseline)
x0ec153l
QTc (Baz) Time, V6
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead V6
Integer
ECG 10s (CHRIS baseline)
x0ec153f
QTc (Baz) Time, aVF
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead aVF
Integer
ECG 10s (CHRIS baseline)
x0ec153e
QTc (Baz) Time, aVL
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead aVL
Integer
ECG 10s (CHRIS baseline)
x0ec153d
QTc (Baz) Time, aVR
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead aVR
Integer
ECG 10s (CHRIS baseline)
x0ec154b
QTc (Baz), percent of the target
QTc, calculated with Bazett formula, expressed as percentange of the target value of 390ms
Float
ECG 10s (CHRIS baseline)
x0ec151a
QTc (Frid) Dispersion
QTc dispersion is defined as the difference between the longest and the shortest QTc duration (with Fridericia formula) measured in the 12 ECG leads, expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec152
QTc (Frid) Time
Duration of QT interval adjusted for a standard heart-rate of 60bpm with Fridericia formula, expressed in milliseconds
Integer
ECG 10s (CHRIS baseline)
x0ec152a
QTc (Frid) Time, I
Duration of QT interval adjusted for the heart-rate with Fridericia formula, expressed in milliseconds, measured in lead I
Integer
ECG 10s (CHRIS baseline)
x0ec152b
QTc (Frid) Time, II
Duration of QT interval adjusted for the heart-rate with Fridericia formula, expressed in milliseconds, measured in lead II
Integer
ECG 10s (CHRIS baseline)
x0ec152c
QTc (Frid) Time, III
Duration of QT interval adjusted for the heart-rate with Fridericia formula, expressed in milliseconds, measured in lead III
Integer
ECG 10s (CHRIS baseline)
x0ec152g
QTc (Frid) Time, V1
Duration of QT interval adjusted for the heart-rate with Fridericia formula, expressed in milliseconds, measured in lead V1
Integer
ECG 10s (CHRIS baseline)
x0ec152h
QTc (Frid) Time, V2
Duration of QT interval adjusted for the heart-rate with Fridericia formula, expressed in milliseconds, measured in lead V2
Integer
ECG 10s (CHRIS baseline)
x0ec152i
QTc (Frid) Time, V3
Duration of QT interval adjusted for the heart-rate with Fridericia formula, expressed in milliseconds, measured in lead V3
Integer
Previous
1
29
30
31
32
33
43
Next